NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Accessibility StatementSkip Navigation "We are continuing to add to a record year with 225%Â revenue growth, Adjusted EBITDA attributable to Nutex Health of 166.0 million. Our financial performance highlights the strength of the business model with our strong balance sheet positioning us well for our planned growth strategy," stated Jon Bates, Chief Financial Officer of Nutex Health. "We are very pleased to deliver another s ...